| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |